Redoxis

Redoxis

07 Oct, 2015

Redoxis is a CRO with core expertise and focus on preclinical drug development and efficacy evaluation in models of inflammatory and autoimmune diseases. With the roots in academic research we strive to be up to date with the latest immunology research and are continuously updating our portfolio of models.

Staying connected with academic research is important to us. We have on-going collaborations with academic partners for model development and are members of several EU funded projects aiming at developing standardized models for autoimmune conditions.

About Us

A non-profit member organization dedicated to accelerate the development of new diagnostics and drugs in inflammation. It is a venue for scientists, clinicians, innovators and industry members.

Network

Founders and future members include academic research insitutions, biotechnology companies, pharmaceutical companies, patient organizations, university hospitals, universities, support groups, financial institutions and regional development players.

NORIN uses cookies for analysis of traffic to the web pages only. The information does not contain personal information and is stored in the analysis tool. NORIN uses this to optimize and improve content.